302 related articles for article (PubMed ID: 25689881)
1. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: the experience of a single center.
Okada N; Sanada Y; Hirata Y; Yamada N; Wakiya T; Ihara Y; Urahashi T; Miki A; Kaneda Y; Sasanuma H; Fujiwara T; Sakuma Y; Shimizu A; Hyodo M; Yasuda Y; Mizuta K
Pediatr Transplant; 2015 May; 19(3):279-86. PubMed ID: 25689881
[TBL] [Abstract][Full Text] [Related]
2. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
3. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.
Lee J; Lee JG; Lee JJ; Kim MS; Ju MK; Choi GH; Choi JS; Kim SI; Joo DJ
Transplant Proc; 2015 Apr; 47(3):723-6. PubMed ID: 25891718
[TBL] [Abstract][Full Text] [Related]
4. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
[TBL] [Abstract][Full Text] [Related]
5. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
[TBL] [Abstract][Full Text] [Related]
6. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
Lee EC; Kim SH; Shim JR; Park SJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
Sugiyama K; Hyodo Y; Aikawa A
Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
[TBL] [Abstract][Full Text] [Related]
8. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
Kim JD; Choi DL; Kim SG; Lee AJ
Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
[TBL] [Abstract][Full Text] [Related]
9. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
[TBL] [Abstract][Full Text] [Related]
10. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
12. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
[TBL] [Abstract][Full Text] [Related]
13. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
[TBL] [Abstract][Full Text] [Related]
15. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
16. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
[TBL] [Abstract][Full Text] [Related]
17. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
18. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
